This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Lori Ann Enney: Innovator in Stroke Treatment
Introduction
Lori Ann Enney is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of medical science, particularly in the treatment of stroke. Her innovative approach focuses on the administration of anti-MAG antibodies, which has the potential to improve outcomes for stroke patients.
Latest Patents
Lori Ann Enney holds 1 patent for her invention titled "Treatment of stroke comprising anti-MAG antibodies." This patent outlines a dosing regimen for the treatment of stroke, specifically addressing the administration of two doses of anti-MAG antibodies for ischemic and/or hemorrhagic stroke. This groundbreaking work aims to enhance the therapeutic options available for stroke patients.
Career Highlights
Throughout her career, Lori has been associated with Glaxo Group Limited, where she has been able to apply her expertise in a collaborative environment. Her work has been instrumental in advancing the understanding and treatment of stroke, showcasing her dedication to improving patient care.
Collaborations
Lori Ann Enney has worked alongside notable colleagues such as Volker Germaschewski and Monica Simeoni. These collaborations have enriched her research and contributed to the development of innovative treatment strategies.
Conclusion
Lori Ann Enney's contributions to stroke treatment through her patent on anti-MAG antibodies highlight her role as a key innovator in the medical field. Her work continues to inspire advancements in therapeutic approaches for stroke patients.